ArticleInternational journal of ophthalmology2026
Development of a novel ultraviolet-polymerized hydrogel as an orbital implant.
Article in International journal of ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimTo prepare ultraviolet (UV)-crosslinked hydrogel serving as a biocompatible orbital filler, and to explore its biological characteristics as well as its efficacy in expanding orbital soft tissue.
methodsA novel medical hydrogel was fabricated
resultsThe target hydrogel was successfully synthesized by photopolymerization, which possessed typical three-dimensional network structure, favorable hydrophilicity, appropriate swelling behavior and satisfactory mechanical performance. Biosafety evaluations confirmed its good biocompatibility with no obvious cytotoxicity, hemolytic reaction or abnormal cell apoptosis observed.
conclusionThe UV-crosslinked medical hydrogel prepared in this study has stable physicochemical properties and excellent biocompatibility. It can effectively expand orbital tissue.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.